GB202117519D0 - Ion channel modulators - Google Patents

Ion channel modulators

Info

Publication number
GB202117519D0
GB202117519D0 GBGB2117519.5A GB202117519A GB202117519D0 GB 202117519 D0 GB202117519 D0 GB 202117519D0 GB 202117519 A GB202117519 A GB 202117519A GB 202117519 D0 GB202117519 D0 GB 202117519D0
Authority
GB
United Kingdom
Prior art keywords
ion channel
channel modulators
modulators
ion
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2117519.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GBGB2117519.5A priority Critical patent/GB202117519D0/en
Publication of GB202117519D0 publication Critical patent/GB202117519D0/en
Priority to PCT/GB2022/053055 priority patent/WO2023099902A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2117519.5A 2021-12-03 2021-12-03 Ion channel modulators Ceased GB202117519D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2117519.5A GB202117519D0 (en) 2021-12-03 2021-12-03 Ion channel modulators
PCT/GB2022/053055 WO2023099902A1 (en) 2021-12-03 2022-12-02 Ion channel modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2117519.5A GB202117519D0 (en) 2021-12-03 2021-12-03 Ion channel modulators

Publications (1)

Publication Number Publication Date
GB202117519D0 true GB202117519D0 (en) 2022-01-19

Family

ID=80080934

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2117519.5A Ceased GB202117519D0 (en) 2021-12-03 2021-12-03 Ion channel modulators

Country Status (2)

Country Link
GB (1) GB202117519D0 (en)
WO (1) WO2023099902A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202208948D0 (en) * 2022-06-17 2022-08-10 Cambridge Entpr Ltd Therapeutics and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102102109B1 (en) * 2018-07-10 2020-04-20 성균관대학교산학협력단 Suppression composition of sodium leak channel comprising N-Benzhydryl Quinuclidine derivatives

Also Published As

Publication number Publication date
WO2023099902A1 (en) 2023-06-08

Similar Documents

Publication Publication Date Title
IL279064A (en) Ion channel modulators
IL281946A (en) Ion channel modulators
EP4065124A4 (en) Ion channel modulators
EP4054559A4 (en) Charged ion channel blockers and methods for use
EP3938345A4 (en) Charged ion channel blockers and methods for use
EP3937945A4 (en) Charged ion channel blockers and methods for use
EP4054586A4 (en) Charged ion channel blockers and methods for use
EP3998844A4 (en) Channel knifeback
EP3649667A4 (en) Multipole ion guide
GB2587055B (en) Ion guide
EP4055018A4 (en) Phosphonium ion channel blockers and methods for use
GB202117519D0 (en) Ion channel modulators
GB2610091B (en) Ion source
EP3766227A4 (en) Techniques for secure channel communications
GB2575342B (en) Ion guide
GB2606413B (en) Cable channel
GB201711208D0 (en) Ion channel inhibitors
GB202018412D0 (en) Malt-1 modulators ii
GB201804229D0 (en) ION Guide
EP3742319B8 (en) Side channel secure implementation
IL310160A (en) Potassium channel modulators
GB202018411D0 (en) Malt-1 modulators i
GB202213709D0 (en) Ion source assembly
GB202314062D0 (en) Ion guide
GB202217040D0 (en) Ion guide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)